G J Ossenkoppele Selected Research

G J Ossenkoppele Research Topics

Disease

11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2020 - 06/2000
7	Residual Neoplasm 03/2016 - 10/2001
6	Neoplasms (Cancer) 02/2015 - 03/2001
6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2012 - 01/2002
5	Lymphoma (Lymphomas) 04/2014 - 02/2002
3	B-Cell Lymphoma (Lymphoma, B Cell) 04/2014 - 01/2007
3	Hodgkin Disease (Hodgkin's Disease) 02/2013 - 03/2001
3	Multiple Myeloma 02/2013 - 05/2001
2	Cognitive Dysfunction 08/2015 - 04/2014
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2013 - 08/2003
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2011 - 06/2005
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 03/2004 - 03/2001
1	Leukemia 06/2014
1	Dementia (Dementias) 04/2014
1	Depressive Disorder (Melancholia) 04/2014
1	Celiac Disease (Celiac Sprue) 06/2011
1	Enteropathy-Associated T-Cell Lymphoma 06/2011
1	Autoimmune Diseases (Autoimmune Disease) 06/2011
1	Necrosis 04/2008
1	Chromosomal Instability (Chromosome Stability) 01/2008
1	Hypersensitivity (Allergy) 01/2008
1	Opportunistic Infections (Opportunistic Infection) 12/2006
1	Mucormycosis 12/2006
1	Burkitt Lymphoma (Burkitt's Lymphoma) 06/2005
1	Infections 08/2003
1	Thrombocytosis (Thrombocythemia) 08/2003
1	Ulcer 08/2003
1	Glioma (Gliomas) 11/2002
1	Body Weight (Weight, Body) 02/2002
1	Blast Crisis (Blast Phase) 01/2002

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 04/2004 - 06/2000
5	Imatinib Mesylate (Gleevec)FDA Link 06/2012 - 01/2002
4	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 08/2003 - 06/2000
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2013 - 05/2001
3	Pharmaceutical PreparationsIBA 08/2003 - 06/2000
2	Biomarkers (Surrogate Marker)IBA 03/2016 - 03/2016
2	Tyrosine Kinase InhibitorsIBA 05/2012 - 01/2002
2	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2007 - 06/2000
2	Granzymes (Granzyme)IBA 03/2004 - 03/2001
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2003 - 05/2001
1	ivosidenibIBA 12/2020
1	insulin-like growth factor binding protein-related protein 1IBA 06/2014
1	fludarabineIBA 04/2014
1	plerixafor FDA Link 02/2013
1	nilotinib FDA Link 06/2012
1	TNF-Related Apoptosis-Inducing LigandIBA 06/2011
1	Cladribine FDA LinkGeneric 06/2011
1	NF-kappa B (NF-kB)IBA 04/2008
1	TNF Receptor-Associated Factor 2 (TRAF2)IBA 04/2008
1	DNA (Deoxyribonucleic Acid)IBA 01/2008
1	Interferon-alpha (Interferon Alfa)IBA 02/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2006
1	Protease Inhibitors (Protease Inhibitor)IBA 03/2004
1	Histocompatibility Antigens Class IIBA 03/2004
1	Vincristine (Oncovin)FDA LinkGeneric 08/2003
1	Prednisone (Sone)FDA LinkGeneric 08/2003
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2003
1	anagrelide (Agrylin)FDA LinkGeneric 08/2003
1	Hydroxyurea (Hydrea)FDA LinkGeneric 08/2003
1	InterferonsIBA 08/2003
1	Anticonvulsants (Antiepileptic Drugs)IBA 11/2002
1	7-aminoactinomycin DIBA 02/2002
1	Coloring Agents (Dyes)IBA 02/2002
1	Phosphotransferases (Kinase)IBA 01/2002
1	Busulfan (Busulfex)FDA Link 05/2001
1	Melphalan (Alkeran)FDA LinkGeneric 05/2001
1	Biological ProductsIBA 03/2001
1	Monocyte Chemoattractant ProteinsIBA 03/2001
1	Monoclonal AntibodiesIBA 03/2001
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 06/2000
1	Daunorubicin (Cerubidine)FDA LinkGeneric 06/2000
1	Carrier Proteins (Binding Protein)IBA 06/2000
1	multidrug resistance-associated protein 1IBA 06/2000

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 06/2014 - 08/2000
5	Therapeutics 02/2015 - 06/2000
3	Transplantation 02/2013 - 02/2002
3	Stem Cell Transplantation 06/2005 - 05/2001
2	Homologous Transplantation 04/2014 - 11/2011
1	Drug Tapering 08/2015
1	Polypharmacy 04/2014
1	Activities of Daily Living (ADL) 04/2014
1	Autologous Transplantation 02/2013
1	Blood Component Removal (Apheresis) 02/2013
1	Immunotherapy 01/2009
1	Radiotherapy 11/2002
1	BEAM regimen 02/2002